IRIS
CARRIERI, Antonio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.325
AS - Asia 3.550
EU - Europa 3.503
SA - Sud America 845
Continente sconosciuto - Info sul continente non disponibili 397
AF - Africa 128
OC - Oceania 8
Totale 18.756
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.168
SG - Singapore 1.400
IT - Italia 1.057
CN - Cina 812
BR - Brasile 686
DE - Germania 546
SE - Svezia 408
HK - Hong Kong 397
RU - Federazione Russa 344
VN - Vietnam 304
FR - Francia 289
GB - Regno Unito 227
UA - Ucraina 174
FI - Finlandia 141
BD - Bangladesh 125
IN - India 123
CA - Canada 68
ID - Indonesia 66
TR - Turchia 57
AR - Argentina 49
MX - Messico 43
IE - Irlanda 40
NL - Olanda 39
JP - Giappone 38
IQ - Iraq 37
PL - Polonia 36
CI - Costa d'Avorio 35
BE - Belgio 34
CO - Colombia 29
AT - Austria 27
ES - Italia 24
ZA - Sudafrica 24
IR - Iran 22
PK - Pakistan 22
SA - Arabia Saudita 22
CH - Svizzera 20
EC - Ecuador 19
VE - Venezuela 18
CZ - Repubblica Ceca 16
PH - Filippine 16
UZ - Uzbekistan 16
CL - Cile 14
LT - Lituania 14
MY - Malesia 14
EG - Egitto 11
JO - Giordania 11
MA - Marocco 11
CR - Costa Rica 10
JM - Giamaica 10
KE - Kenya 10
PY - Paraguay 9
DK - Danimarca 8
DZ - Algeria 7
TN - Tunisia 7
UY - Uruguay 7
AE - Emirati Arabi Uniti 6
AL - Albania 6
AU - Australia 6
AZ - Azerbaigian 6
DO - Repubblica Dominicana 6
EE - Estonia 6
KR - Corea 6
PE - Perù 6
RO - Romania 6
TH - Thailandia 6
BO - Bolivia 5
GE - Georgia 5
KG - Kirghizistan 5
OM - Oman 5
RS - Serbia 5
BY - Bielorussia 4
GA - Gabon 4
LB - Libano 4
NG - Nigeria 4
NO - Norvegia 4
NP - Nepal 4
PT - Portogallo 4
TT - Trinidad e Tobago 4
TW - Taiwan 4
BA - Bosnia-Erzegovina 3
HU - Ungheria 3
IL - Israele 3
LY - Libia 3
SV - El Salvador 3
AO - Angola 2
BB - Barbados 2
BG - Bulgaria 2
BH - Bahrain 2
ET - Etiopia 2
GR - Grecia 2
GY - Guiana 2
HN - Honduras 2
HR - Croazia 2
IS - Islanda 2
KZ - Kazakistan 2
LA - Repubblica Popolare Democratica del Laos 2
MD - Moldavia 2
MK - Macedonia 2
NI - Nicaragua 2
NZ - Nuova Zelanda 2
Totale 18.329
Salva come PNG Salva come JPEG
Città #
Dallas 2.475
Ashburn 745
Singapore 733
Fairfield 725
San Jose 557
Woodbridge 507
Chandler 505
Houston 397
Hong Kong 380
Jacksonville 357
Milan 335
Nyköping 298
Seattle 288
Cambridge 251
Wilmington 239
Council Bluffs 223
Ann Arbor 222
Beijing 192
Bari 167
Lauterbourg 116
New York 115
Los Angeles 113
Nanjing 113
Lawrence 107
Roxbury 107
Boardman 97
Marseille 97
Rome 86
Dong Ket 84
Santa Clara 84
Ho Chi Minh City 80
Brooklyn 71
Des Moines 64
Munich 59
Princeton 58
Hanoi 56
São Paulo 52
Columbus 48
London 47
Chicago 44
Helsinki 44
San Diego 43
Jakarta 41
Buffalo 39
Dublin 37
Abidjan 35
Figino 33
Tokyo 33
Brussels 32
Jiaxing 32
North Bergen 32
Inglewood 31
Frankfurt am Main 30
Warsaw 30
Nanchang 29
Orem 28
Amsterdam 27
Moscow 27
Turin 27
Chennai 25
Phoenix 24
Rio de Janeiro 24
Atlanta 23
Falkenstein 23
San Francisco 22
Shenyang 22
Denver 21
Nuremberg 21
Paris 20
Redwood City 19
Tianjin 19
Toronto 19
Montreal 18
Mumbai 18
Sannicandro di Bari 18
Guangzhou 17
Boston 16
Changsha 16
Dearborn 16
West Jordan 16
Belo Horizonte 15
Hebei 15
Istanbul 15
Bologna 14
Kansas City 14
Johannesburg 13
Mexico City 13
Naples 13
Stockholm 13
Tashkent 13
Ankara 12
Brasília 12
Manchester 12
Delhi 11
Jeddah 11
Leawood 11
Medellín 11
Shanghai 11
Amman 10
Juiz de Fora 10
Totale 12.590
Salva come PNG Salva come JPEG
Nome #
1, 3‐Benzothiazoles as Antimicrobial Agents 1.131
1,2,3,4-Tetrahydroisoquinoline/2H-chromen-2-one conjugates as nanomolar P-glycoprotein inhibitors: Molecular determinants for affinity and selectivity over multidrug resistance associated protein 1 1.120
1,3-Benzothiazoles as Antimicrobial Agents 1.111
Probiotic and Tea Tree Oil Treatments Improve Therapy of Vaginal Candidiasis: A Preliminary Clinical Study 256
miRNAs for the Detection of MultiDrug Resistance: Overview and Perspectives 235
4H-1,4-benzothiazine, dihydro-1,4-benzothiazinones and 2-amino-5- fluorobenzenethiol derivatives: Design, synthesis and in vitro antimicrobial screening 222
2-Aminobenzothiazole derivatives: Search for new antifungal agents 212
Chasing ChEs-MAO B Multi-Targeting 4-Aminomethyl-7-Benzyloxy-2H-Chromen-2-ones 211
Investigating 1,2,3,4,5,6-hexahydroazepino[4,3-b]indole as scaffold of butyrylcholinesterase-selective inhibitors with additional neuroprotective activities for Alzheimer's disease 204
A convenient synthesis of lubeluzole and its enantiomer: Evaluation as chemosensitizing agents on human ovarian adenocarcinoma and lung carcinoma cells 186
Synthesis, in vitro evaluation, and molecular modeling investigation of benzenesulfonimide peroxisome proliferator-activated receptors α antagonists 183
Bioisosteric Modification of To042: Synthesis and Evaluation of Promising Use-Dependent Inhibitors of Voltage-Gated Sodium Channels 179
The chemosensitizing agent lubeluzole binds calmodulin and inhibits Ca2+/calmodulin-dependent Kinase II 174
Involvement of I2-imidazoline binding sites in positive and negative morphine analgesia modulatory effects 171
Structure-property relationship study of the HPLC enantio-selective retention of neuroprotective 7-[(1-alkylpiperidin-3-yl)methoxy]coumarin derivatives on an amylose-based chiral stationary phase 170
Effect of Methyl -β- Cyclodextrin on the antimicrobial activity of a new series of poorly water-soluble benzothiazoles 169
Beyond the Canonical Endocannabinoid System. A Screening of PPAR Ligands as FAAH Inhibitors 169
,3-Benzothiazoles as Antimicrobial Agents 168
1,3,5-triazine derivatives as dual inhibitors of 5-HT6R/FAAH in search of new therapy for Alzheimer's disease 163
In vitro interactions between anidulafungin and nonsteroidal anti-inflammatory drugs on biofilms of Candida spp 161
2-(2-Phenylcyclopropyl)-Imidazolines: Reversed Enantioselective Interaction At I1 and I2 Imidazoline Receptors 159
New tetrahydroisoquinoline-based P-glycoprotein modulators: Decoration of the biphenyl core gives selective ligands 159
Structure-Activity Relationship Studies on Tetrahydroisoquinoline Derivatives: [4′-(6,7-Dimethoxy-3,4-dihydro-1H-isoquinolin-2-ylmethyl)biphenyl-4-ol] (MC70) Conjugated through Flexible Alkyl Chains with Furazan Moieties Gives Rise to Potent and Selective Ligands of P-glycoprotein 155
Synthesis.and biological evaluation of pyridazino[4,3-b]indoles and indeno[1,2-c]pyridazines as new ligands of central and peripheral benzodiazepine receptors 149
Derivatives of Tenuazonic Acid as Potential New Multi-Target Anti-Alzheimer’s Disease Agents 149
Alpidem analogues containinig a GABA or glycine moiety as new anticonvulsant agents 146
Repositioning of Endonuclear Receptors Binders as Potential Antibacterial and Antifungal Agents. Eptyloxìm: A Potential and Novel Gyrase B and Cytochrome Cyp51 Inhibitor 146
Structural Determinants in the Binding of BB2 Receptor Ligands: In Silico, X-Ray and NMR Studies in PD176252 Analogues. 142
Ligands of neuronal nicotinic acetylcholine receptor (nAChR): inferences from the Hansch and 3-D Quantitative Structure-Activity Relationship (QSAR) models 140
High Affinity Central Benzodiazepine Receptor Ligands. Part 2: Quantitative Structure-Activity Relationships and Comparative Molecular Field Analysis of Pyrazolo[4,3-c]quinolin-3-ones 139
Lipophilicity of teicoplanin antibiotics as assessed by reversed phase high-performance liquid chromatography: quantitative structure-property and structure-activity relationships 136
Coumarin, chromone, and 4(3H)-pyrimidinone novel bicyclic and tricyclic derivatives as antiplatelet agents: synthesis, biological evaluation, and comparative molecular field analysis 134
Elucidation of the synergistic action of Mentha Piperita essential oil with common antimicrobials 134
A New Series of Aryloxyacetic Acids Endowed with Multi-Target Activity towards Peroxisome Proliferator-Activated Receptors (PPARs), Fatty Acid Amide Hydrolase (FAAH), and Acetylcholinesterase (AChE) 133
3D-QSAR models and docking studies of reversible inhibitors of type A and B Monoamine Oxidases 132
(contributo in convegno) MOLECULAR DETERMINANTS FOR NUCLEAR RECEPTORS SELECTIVITY; CHEMOMETRIC ANALYSIS, DOCKINGS AND SITE-DIRECTED MUTAGENESIS OF DUAL PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS α/γ AGONISTS 128
Investigation on platelet aggregation inhibitory activity by phenyl amides and esters of piperidinecarboxylic acids 127
The Versatile 2-Substituted Imidazoline Nucleus as a Structural Motif of Ligands Directed to the Serotonin 5-HT1A Receptor 127
Ligand binding to I2 imidazoline receptor: the role of lipophilicity in quantitative structure-activity relationship models. 125
Design, synthesis and biological evaluation of a class of bioisosteric oximes of the novel dual peroxisome proliferator-activated receptor alpha/gamma ligand LT175 125
Understanding of the MAO-A and B Reversible Inhibitory Activity and Selectivity by Using 3D Descriptors of Lipophilicity 124
Allyphenyline Analogues Potentially Useful in the Management of Chronic Pain and Opioid Addiction 123
Evaluation of water‐soluble Mannich base prodrugs of 2,3,4,5‐tetrahydroazepino[4,3‐b]indol‐1(6H)‐one as multitarget‐directed agents for Alzheimer’s disease 123
Chiral pyrrolidines as multipotent agents in Alzheimer and neurodegenerative diseases 120
MOLECULAR DETERMINANTS FOR NUCLEAR RECEPTORS SELECTIVITY: CHEMOMETRIC ANALYSIS, DOCKINGS AND SITE-DIRECTED MUTAGENESIS OF DUAL PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS α/γ AGONISTS 120
Papain catalyzed hydrolysis of aryl esters: a comparison of the Hansch, Docking and CoMFA methods 119
The in silico insights of α-adrenergic receptors over the last decade: methodological approaches and structural features of the 3D models 119
2-D and 3-D modeling of imadazoline receptor ligands: insights into pharmacophore 119
Lubeluzole: from anti-ischemic to chemosensitizing agent 119
Guinea-pig ileum as ex vivo model useful to characterize ligands displaying Imidazoline I2 and Adrenergic alpha2 mixed activity: a preliminary study 117
Diffuse Intrinsic Pontine Glioma (DIPG): breakthrough and clinical perspective 116
alpha2-adrenoreceptors profile modulation and high antinociceptive activity of (S)-(-)-2-[1-(Biphenyl-2-yloxy)ethyl]-4,5-dihydro-1H-imidazole 115
Alpha2-adrenoreceptors profile modulation. 3.1 (R)-(+)-m-nitrobiphenyline, a new efficient and alpha2C-subtype selective agonist 115
Enhanced solubility and antibacterial activity of lipophilic fluoro-substituted N-benzoyl-2-aminobenzothiazoles by complexation with beta-cyclodextrins 115
Neuronal Nicotinic Agonists: a Multi-approach Development of the Pharmacophore 114
Rational design of the new antihypertensive I1-receptor ligand 2-(2-biphenyl-2-yl-1-methyl-ethyl-)4,5-dihydro-1H-imidazole 114
Dioxane and oxathiane nuclei: suitable substructures for muscarinic agonists 114
Analisi conduttimetrica 114
Binding Models of Reversible Inhibitors to Monoamine Oxidases 113
Natural and synthetic geiparvarins are strong and selective MAO-B inhibitors. Synthesis and SAR studies. 112
Non-Antibiotic Drug Repositioning as an Alternative Antimicrobial Approach 107
High affinity central benzodiazepine receptor ligands: synthesis and structure-activity relationship studies of a new series of pyrazolo[4,3-c]quinolin-3-ones. 107
A twenty-year journey exploring coumarin-based derivatives as bioactive molecules 106
High affinity central benzodiazepine receptor ligands II: QSAR studies and CoMFA analysis pyrazolo(4,3-c)quinolin-3-ones 106
Might the observed a2A-adrenoreceptor agonism or antagonism of allyphenyline analogues be ascribed to different molecular conformations? 106
Neuronal nicotinic receptor agonists: multi-approach pharmacophore development and 3D-QSAR predictive models, 105
Rivastigmine structure-based hybrids as potential multi-target anti-Alzheimer’s drug candidates 105
Novel Phenothiazine/Donepezil-Like Hybrids Endowed with Antioxidant Activity for a Multi-Target Approach to the Therapy of Alzheimer’s Disease 103
Exploring the Antibiofilm Effect of Sertraline in Synergy with Cinnamomum verum Essential Oil to Counteract Candida Species 102
Antifungal Biofilm Inhibitory Effects of Combinations of Diclofenac and Essential Oils 102
alfa2-adrenoreceptors profile modulation. 2.1 Biphenyline analogues as tools for selective activation of alfa2C-subtype 99
Conformationally constrained butyrophenones with mixed dopaminergic (D(2)) and serotoninergic (5-HT(2A), 5-HT(2C)) affinities: synthesis, pharmacology, 3D-QSAR, and molecular modeling of (aminoalkyl)benzo- and -thienocycloalkanones as putative atypical antipsychotics. 99
Structure-based design of novel donepezil-like hybrids for a multi-target approach to the therapy of Alzheimer's disease 98
Binding models of reversible inhibitors to type-B monoamine oxidase 97
Pharmacophore development and 3D-QSAR study of I1 imidazoline binding site ligands 97
Design, Synthesis, Biological Evaluation, and Computational Studies of Novel Ureidopropanamides as Formyl Peptide Receptor 2 (FPR2) Agonists to Target the Resolution of Inflammation in Central Nervous System Disorders 97
Enantiomeric Separation and Molecular Modelling of Bioactive 4-Aryl-3,4-dihydropyrimidin-2(1H)-one Ester Derivatives on Teicoplanin-Based Chiral Stationary Phase 96
Antibiofilm Effects of Plant Extracts Against Staphylococcus aureus 94
Linezolid hybrid analogs: synthesis and antimicrobial studies of oxalodinone-mercaptobenzothiazole compounds 94
Modeling the structural basis of the human CCR5 chemokine receptor functions: from homology model-builiding and molecular dynamics validation to agonist and anatgonist docking 94
Sintesi alternativa del lubeluzolo e del suo enantiomero e valutazione come agenti in grado di potenziare l'effetto di farmaci antitumorali. 94
Molecular determinants for nuclear receptors selectivity: chemometric analysis, dockings and site-directed mutagenesis of dual peroxisome proliferator-activated receptors alpha/gamma agonists 94
2D- and 3D-QSAR of tocainide and mexiletine analogues acting as Na(v)1.4 channel blockers 94
Comparative Molecular Field Analysis of pyridawinone-containing alfa1-antagonists 93
New molecular requirements of Toc derivatives bearing a novel class of Nav1.4 blockers 92
Enhanced antibacterial efficacy of new benzothiazole phthalimide hybrid compounds/methyl--cyclodextrin inclusion complexes compared to the free forms: insights into the possible mode of action 91
Binding of tracizolines to the imidazoline receptor: the role of lipophilicity in quantitative structure-activity relationship models 91
Novel 6-alkyl-bridged 4-arylalkylpiperazin-1-yl derivatives of azepino[4,3-b]indol-1(2H)-one as potent BChE-selective inhibitors showing protective effects against neurodegenerative insults 89
Neuronal nicotinic receptor agonists: multi-approach pharmacophore development and 3D QSAR predictive models 88
Dimeric analogs of the dual PPARα/γ agonist LT-175: design, synthesis and biological evaluation. 85
Benzothiazole-Phthalimide Hybrids as Anti-Breast Cancer and Antimicrobial Agents 84
Recent Trends And Future Prospects In Computational GPCR Drug Discovery: From Virtual Screening To Polypharmacology. 84
Multiple causes, multiple targets: FAAH as a centerpiece for therapy of multifactorial pathologies. 84
SAR of Non-Nucleoside HIV-1 RT inhibitors (NNRTIs): Comparative Molecular field Analysis (CoMFA) and Docking Studies 83
Scouting around 1,2,3,4-Tetrahydrochromeno[3,2-c]pyridin-10-ones for Single- and Multitarget Ligands Directed towards Relevant Alzheimer's Targets 83
Evaluation of the Potential Cytoprotective Effect of Melatonin in Comparison with Vitamin E and Trolox against Cd2+-Induced Toxicity in SH-SY5Y, HCT 116, and HepG2 Cell Lines 82
N‑Aryl-2,6-dimethylbenzamides, a new generation of tocainide analogues as blockers of skeletal muscle voltage-gated sodium channels 82
Multi-Target Approach for the Design of New Compounds Potentially Useful for the Prevention and Treatment of Cardiovascular and/or Neurodegenerative Diseases 82
Extended form of a retro-inverso peptide stabilized by beta-sheet unidirectional H-bonds: Crystallographic and NMR evidence 81
DESIGN, SYNTHESIS AND BIOLOGICAL EVALUATION OF NEW ANALOGS OF THE DUAL PPARα/γ AGONIST LT175. 78
Totale 15.473
Salva come PNG Salva come JPEG
Categoria #
all - tutte 67.201
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 67.201
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022703 0 0 11 41 22 48 49 44 56 84 134 214
2022/20231.556 220 141 93 125 183 190 14 155 337 22 40 36
2023/2024675 44 99 26 43 52 102 40 29 39 54 52 95
2024/20252.436 73 69 196 109 66 165 221 233 148 145 356 655
2025/20267.950 698 773 2.169 677 565 352 583 213 535 542 215 628
2026/2027635 160 281 194 0 0 0 0 0 0 0 0 0
Totale 18.756